Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficiency of the EmERGE Pathway of Care in Five European HIV Centres.
Beck EJ, Mandalia S, Yfantopoulos P, Leon A, Merino MJ, Garcia F, Wittevogel M, Apers L, Benkovic I, Zekan S, Begovac J, Cunha AS, Teofilo E, Rodrigues G, Borges MDF, Fatz D, Vera J, Whetham J; EmERGE Consortium. Beck EJ, et al. Among authors: teofilo e. Pharmacoeconomics. 2022 Dec;40(12):1235-1246. doi: 10.1007/s40273-022-01193-z. Epub 2022 Oct 13. Pharmacoeconomics. 2022. PMID: 36227463
Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study.
Teófilo E, Rocha-Pereira N, Kuhlmann B, Antela A, Knechten H, Santos J, Jiménez-Expósito MJ; REMAIN study group. Teófilo E, et al. HIV Clin Trials. 2016 Feb;17(1):17-28. doi: 10.1080/15284336.2015.1112494. HIV Clin Trials. 2016. PMID: 26899539 Free PMC article. Clinical Trial.
Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study.
Esser S, Haberl A, Mulcahy F, Gölz J, Lazzarin A, Teofilo E, Vera J, Körber A, Staszewski S. Esser S, et al. Among authors: teofilo e. Eur J Med Res. 2011 Oct 10;16(10):427-36. doi: 10.1186/2047-783x-16-10-427. Eur J Med Res. 2011. PMID: 22024421 Free PMC article.
HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.
Cavaco-Silva J, Abecasis A, Miranda AC, Poças J, Narciso J, Águas MJ, Maltez F, Almeida I, Germano I, Diniz A, Gonçalves Mde F, Gomes P, Cunha C, Camacho RJ; Portuguese HIV-2 Resistance Study Group. Cavaco-Silva J, et al. PLoS One. 2014 Mar 28;9(3):e92747. doi: 10.1371/journal.pone.0092747. eCollection 2014. PLoS One. 2014. PMID: 24681625 Free PMC article.
The demise of multidrug-resistant HIV-1: the national time trend in Portugal.
Vercauteren J, Theys K, Carvalho AP, Valadas E, Duque LM, Teófilo E, Faria T, Faria D, Vera J, Aguas MJ, Peres S, Mansinho K, Vandamme AM, Camacho RJ; Portuguese HIV-1 Resistance Study Group. Vercauteren J, et al. Among authors: teofilo e. J Antimicrob Chemother. 2013 Apr;68(4):911-4. doi: 10.1093/jac/dks470. Epub 2012 Dec 9. J Antimicrob Chemother. 2013. PMID: 23228933 Free PMC article.
42 results